{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:29Z","timestamp":1786119449122,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/mjt.0b013e3181c42758","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T04:15:25Z","timestamp":1269404125000},"page":"e71-e74","source":"Crossref","is-referenced-by-count":8,"title":["New Therapeutic Option With N-acetylcysteine for Primary Sclerosing Cholangitis: Two Case Reports"],"prefix":"10.1097","volume":"18","author":[{"given":"Burhan","family":"Ozdil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Cosar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet","family":"Akkiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macit","family":"Sandikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Kece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0016-5085(90)91038-8","article-title":"Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.","volume":"99","author":"Hayashi","year":"1990","journal-title":"Gastroenterology"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial.","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199703063361009","article-title":"Toward better treatment of primary sclerosing cholangitis.","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2353\/ajpath.2006.060146","article-title":"MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.","volume":"169","author":"Finzi","year":"2006","journal-title":"Am J Pathol"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.4049\/jimmunol.178.3.1800","article-title":"Airway epithelial NF-kappa B activation modulates asbestos-induced inflammation and mucin production in vivo.","volume":"178","author":"Haegens","year":"2007","journal-title":"J Immunol"},{"key":"R8-15-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00044011-200525060-00005","article-title":"High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease.","volume":"25","author":"Zuin","year":"2005","journal-title":"Clin Drug Investig"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(98)90506-6","article-title":"Characterization of N-acetylcysteine and ambroxol in antioxidant therapy.","volume":"92","author":"Gillissen","year":"1998","journal-title":"Respir Med"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction withhydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid.","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Rad Biol Med"},{"key":"R11-15-20210202","first-page":"45","article-title":"Toxicological, pharmacokinetic andmetabolic studies on acetylcysteine.","volume":"111","author":"Bonanomi","year":"1980","journal-title":"Eur J Respir Dis Suppl"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2362.2000.00736.x","article-title":"N-Acetylcysteine replenishes glutathione in HIV infection.","volume":"30","author":"De Rosa","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jcp.20066","article-title":"N-Acetylcysteine inhibits Na absorption across human nasal epithelial cells.","volume":"201","author":"Rochat","year":"2004","journal-title":"J Cell Physiol"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/BF02044114","article-title":"N-Acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid.","volume":"22","author":"De Backer","year":"1996","journal-title":"Intensive Care Med"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/pupt.1999.0219","article-title":"N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs.","volume":"12","author":"Nawrocka","year":"1999","journal-title":"Pulmon Pharmacol Ther"},{"key":"R16-15-20210202","first-page":"325","article-title":"Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells.","volume":"57","author":"Radomska-Lesniewska","year":"2006","journal-title":"J Physiol Pharmacol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181c42758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:34Z","timestamp":1786040374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201105000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181c42758","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}